Ticker
PALICompany Name
PALISADE BIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -11.71M | 0% | $ 0 |
3/31/2025 | $ -13.01M | 0% | $ 0 |
12/31/2024 | $ -14.31M | 0% | $ 0 |
9/30/2024 | $ -13.95M | 0% | $ 0 |
6/30/2024 | $ -14.06M | 0% | $ 0 |
3/31/2024 | $ -13.38M | 0% | $ 0 |
12/31/2023 | $ -12.2M | -4878% | $ 250K |
9/30/2023 | $ -12.93M | -5171.6% | $ 250K |
6/30/2023 | $ -13.31M | -5323.6% | $ 250K |
3/31/2023 | $ -12.24M | -4894.4% | $ 250K |
EBITDA / Revenues
(=) EBITDA %
EBITDA % for PALISADE BIO INC is calculated as follows: EBITDA [ $ -13.75M ] / Revenues [ $ 13.52K ]
(=) EBITDA % [ -101734.08% ]
Minimum
Sep 30, 2021
Maximum
Dec 31, 2023
Average
Median
filtered constituents | 3.29K |
---|---|
min | -74.33% |
max | 97.24% |
average | 16.2% |
median | 14.74% |
std | 26.73% |